These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 37185870)

  • 1. Dysbiosis of oropharyngeal microbiome and antibiotic resistance in hospitalized COVID-19 patients.
    Wu J; Liu W; Zhu L; Li N; Luo G; Gu M; Peng M; Zeng S; Wu S; Zhang S; Chen Q; Cai M; Cao W; Jiang Y; Luo C; Tian D; Shi M; Shu Y; Chang G; Luo H
    J Med Virol; 2023 Apr; 95(4):e28727. PubMed ID: 37185870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metatranscriptomic Analysis Reveals Disordered Alterations in Oropharyngeal Microbiome during the Infection and Clearance Processes of SARS-CoV-2: A Warning for Secondary Infections.
    Zhou Y; Lu S; Wei X; Hu Y; Li H; Wang J; Lin Y; Li M; Wang M; Ma J; Zhu Z; Yang S; Ying B; Zhang W; Chen B; Li W
    Biomolecules; 2022 Dec; 13(1):. PubMed ID: 36671391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe Dysbiosis and Specific Haemophilus and Neisseria Signatures as Hallmarks of the Oropharyngeal Microbiome in Critically Ill Coronavirus Disease 2019 (COVID-19) Patients.
    de Castilhos J; Zamir E; Hippchen T; Rohrbach R; Schmidt S; Hengler S; Schumacher H; Neubauer M; Kunz S; Müller-Esch T; Hiergeist A; Gessner A; Khalid D; Gaiser R; Cullin N; Papagiannarou SM; Beuthien-Baumann B; Krämer A; Bartenschlager R; Jäger D; Müller M; Herth F; Duerschmied D; Schneider J; Schmid RM; Eberhardt JF; Khodamoradi Y; Vehreschild MJGT; Teufel A; Ebert MP; Hau P; Salzberger B; Schnitzler P; Poeck H; Elinav E; Merle U; Stein-Thoeringer CK
    Clin Infect Dis; 2022 Aug; 75(1):e1063-e1071. PubMed ID: 34694375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Temporal dynamics of oropharyngeal microbiome among SARS-CoV-2 patients reveals continued dysbiosis even after Viral Clearance.
    Paine SK; Rout UK; Bhattacharyya C; Parai D; Alam M; Nanda RR; Tripathi D; Choudhury P; Kundu CN; Pati S; Bhattacharya D; Basu A
    NPJ Biofilms Microbiomes; 2022 Aug; 8(1):67. PubMed ID: 36002454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Limited Impact of SARS-CoV-2 on the Human Naso-Oropharyngeal Microbiota in Hospitalized Patients.
    Lai CKC; Cheung MK; Lui GCY; Ling L; Chan JYK; Ng RWY; Chan HC; Yeung ACM; Ho WCS; Boon SS; Chan PKS; Chen Z
    Microbiol Spectr; 2022 Dec; 10(6):e0219622. PubMed ID: 36350127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Signatures of COVID-19 Severity and Immune Response in the Respiratory Tract Microbiome.
    Merenstein C; Liang G; Whiteside SA; Cobián-Güemes AG; Merlino MS; Taylor LJ; Glascock A; Bittinger K; Tanes C; Graham-Wooten J; Khatib LA; Fitzgerald AS; Reddy S; Baxter AE; Giles JR; Oldridge DA; Meyer NJ; Wherry EJ; McGinniss JE; Bushman FD; Collman RG
    mBio; 2021 Aug; 12(4):e0177721. PubMed ID: 34399607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization.
    Zuo T; Zhang F; Lui GCY; Yeoh YK; Li AYL; Zhan H; Wan Y; Chung ACK; Cheung CP; Chen N; Lai CKC; Chen Z; Tso EYK; Fung KSC; Chan V; Ling L; Joynt G; Hui DSC; Chan FKL; Chan PKS; Ng SC
    Gastroenterology; 2020 Sep; 159(3):944-955.e8. PubMed ID: 32442562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metatranscriptomic analysis revealed
    Lu S; Zhou Y; Hu Y; Wang J; Li H; Lin Y; Wang D; Xian J; Zhao S; Ma J; Zhu Z; Yang S; Meng Q; Kang Y; Chen B; Li W
    Front Cell Infect Microbiol; 2023; 13():1161763. PubMed ID: 37333851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of infection with COVID-19 on the respiratory microbiome: A narrative review.
    Zhu T; Jin J; Chen M; Chen Y
    Virulence; 2022 Dec; 13(1):1076-1087. PubMed ID: 35763685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations of the gut microbiota in coronavirus disease 2019 and its therapeutic potential.
    Xiang H; Liu QP
    World J Gastroenterol; 2022 Dec; 28(47):6689-6701. PubMed ID: 36620345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic, Prognostic, and Therapeutic Roles of Gut Microbiota in COVID-19: A Comprehensive Systematic Review.
    Farsi Y; Tahvildari A; Arbabi M; Vazife F; Sechi LA; Shahidi Bonjar AH; Jamshidi P; Nasiri MJ; Mirsaeidi M
    Front Cell Infect Microbiol; 2022; 12():804644. PubMed ID: 35310853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of microbiota in the gut and upper respiratory tract associated with SARS-CoV-2 infection.
    Li J; Jing Q; Li J; Hua M; Di L; Song C; Huang Y; Wang J; Chen C; Wu AR
    Microbiome; 2023 Mar; 11(1):38. PubMed ID: 36869345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Fungal Gut Microbiome Exhibits Reduced Diversity and Increased Relative Abundance of Ascomycota in Severe COVID-19 Illness and Distinct Interconnected Communities in SARS-CoV-2 Positive Patients.
    Reinold J; Farahpour F; Schoerding AK; Fehring C; Dolff S; Konik M; Korth J; van Baal L; Buer J; Witzke O; Westendorf AM; Kehrmann J
    Front Cell Infect Microbiol; 2022; 12():848650. PubMed ID: 35521219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoimmunity and COVID-19 - The microbiotal connection.
    Katz-Agranov N; Zandman-Goddard G
    Autoimmun Rev; 2021 Aug; 20(8):102865. PubMed ID: 34118455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-read 16S-seq reveals nasopharynx microbial dysbiosis and enrichment of
    Prasad P; Mahapatra S; Mishra R; Murmu KC; Aggarwal S; Sethi M; Mohapatra P; Ghosh A; Yadav R; Dodia H; Ansari SA; De S; Singh D; Suryawanshi A; Dash R; Senapati S; Beuria TK; Chattopadhyay S; Syed GH; Swain R; Raghav SK; Parida A
    Mol Omics; 2022 Jul; 18(6):490-505. PubMed ID: 35506682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut and airway microbiota and their role in COVID-19 infection and pathogenesis: a scoping review.
    Liu TFD; Philippou E; Kolokotroni O; Siakallis G; Rahima K; Constantinou C
    Infection; 2022 Aug; 50(4):815-847. PubMed ID: 34671922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Social Distancing Imposed To Contain COVID-19 Can Affect Our Microbiome: a Double-Edged Sword in Human Health.
    Domingues CPF; Rebelo JS; Dionisio F; Botelho A; Nogueira T
    mSphere; 2020 Sep; 5(5):. PubMed ID: 32938697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammation-type dysbiosis of the oral microbiome associates with the duration of COVID-19 symptoms and long COVID.
    Haran JP; Bradley E; Zeamer AL; Cincotta L; Salive MC; Dutta P; Mutaawe S; Anya O; Meza-Segura M; Moormann AM; Ward DV; McCormick BA; Bucci V
    JCI Insight; 2021 Oct; 6(20):. PubMed ID: 34403368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the Microbiome in the Pathogenesis of COVID-19.
    De R; Dutta S
    Front Cell Infect Microbiol; 2022; 12():736397. PubMed ID: 35433495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.